https://www.selleckchem.com/pr....oducts/chloroquine.h
ty after SAR is comparable with primary AAA-repair. BACKGROUND Distal bypass is the optimal treatment for patients with critical limb ischemia (CLI). However, effectiveness of redo distal bypass (rD after failed initial distal bypass (iD remains uncertain. This study aimed to analyze long-term results of rDB for CLI. METHODS Patients undergoing rDB for CLI from 2009 to 2018 at a single institute were retrospectively reviewed. Operative details, primary and secondary patency, survival rate, major amputation free rate, and risk fa
Like
Comment
Share
